Infectious Diseases

Infectious diseases is the branch of internal medicine that deals with illnesses caused by microorganisms—bacteria, viruses, fungi, protozoa, and helminths—and with the body's response to them.

17 frameworks, from 400 BCE to today · Internal Medicine · Medicine & Health

still a working view ended · each leads to its entry below

Overview

Infectious diseases is the branch of internal medicine that deals with illnesses caused by microorganisms—bacteria, viruses, fungi, protozoa, and helminths—and with the body's response to them. Its practitioners diagnose and treat pneumonia, sepsis, tuberculosis, HIV, malaria, endocarditis, meningitis, and hundreds of other conditions; they also run infection-control programs, steward antibiotic use, and respond to outbreaks. What makes the field distinctive is that its central objects were invisible for most of human history. Physicians could observe fevers, pustules, and contagion's spread, but the causal agents remained speculative until the late nineteenth century. The history of infectious diseases is therefore a history of learning to see: first with better instruments, then with culture media, then with molecular tools—and, alongside each new way of seeing, a new way of intervening.

Humoral Medicine and the Miasma Theory

For roughly two millennia, Western medicine explained epidemic disease through the framework inherited from Hippocratic and Galenic writings. Health depended on the balance of four humors—blood, phlegm, yellow bile, and black bile—and disease arose when that balance was disturbed12. Fevers were understood as the body's effort to expel corrupt matter; treatments aimed to assist that expulsion through bleeding, purging, and diet.

When plagues swept through cities, physicians reached for a second explanation: miasma, or "bad air." The miasma theory held that epidemics arose from foul emanations given off by decaying organic matter, swamps, and crowded unsanitary quarters3. It was not irrational—it correctly identified filth and crowding as correlates of disease—but it located the cause in the air rather than in transmissible agents3. Its practical legacy was sanitary reform: cleaning streets, draining marshes, and improving water supplies. These measures saved lives, though often for reasons their advocates did not fully understand.

Against miasma stood contagionism, the older idea that disease can pass from person to person or through contaminated objects (fomites). Contagionists pointed to the observable spread of smallpox and the apparent effectiveness of quarantine. The two camps competed for centuries, and the debate was not merely academic: it determined whether governments invested in sanitation or in isolation. In practice, many physicians held both views at once, attributing some diseases to air and others to contact.

Smallpox Inoculation and the Birth of Vaccinology

The first great practical breakthrough came from observation rather than theory. In the early eighteenth century, variolation—deliberately inoculating a person with material from a smallpox pustule to produce a mild case and subsequent immunity—was practiced in China, India, the Ottoman Empire, and eventually Europe and the American colonies. It worked, but carried a real risk of causing full-blown smallpox.

In 1796, the English physician Edward Jenner tested a folk belief that milkmaids who had contracted cowpox were protected against smallpox4567. He inoculated a boy with cowpox material and later exposed him to smallpox; the boy remained well45. Jenner published his findings in 1798, and vaccination—named from the Latin vaccinus, "of the cow"—spread internationally457. The principle was profound: a related but milder agent could confer protection against a lethal one. It would take nearly a century for anyone to explain why it worked.

Sanitation, Vectors, and the Environmental Turn

The nineteenth century brought a wave of reforms that reduced infectious disease burden before the agents were known. John Snow's investigation of the 1854 Broad Street cholera outbreak in London—mapping cases and tracing them to a single water pump—demonstrated that cholera was waterborne, contradicting the miasma account. Snow's work is often cited as a founding moment of epidemiology: the use of systematic observation and mapping to identify a source.

Simultaneously, the recognition of insect vectors transformed understanding of diseases like malaria and yellow fever. In 1880, Alphonse Laveran identified the malaria parasite in the blood of patients; in 1897, Ronald Ross showed that mosquitoes transmitted bird malaria, and later work established the Anopheles mosquito as the vector for human malaria. In 1900, Walter Reed's commission in Cuba demonstrated that yellow fever was transmitted by Aedes aegypti mosquitoes. Vector control—draining breeding sites, screening windows, using insecticides—became a cornerstone of public health, and environmental sanitation joined it as a proven strategy against cholera, typhoid, and dysentery.

Germ Theory and the Rise of Bacteriology

The intellectual revolution that unified the field came in the second half of the nineteenth century8. Louis Pasteur's work on fermentation in the 1850s and 1860s showed that microorganisms were responsible for specific chemical processes and could be killed by heat (pasteurization). In 1861, he demonstrated that microbes caused putrefaction. The implication was radical: specific microscopic organisms could cause specific diseases.

Robert Koch gave the new field its method91011. In the 1870s and 1880s, working first on anthrax and then on tuberculosis, Koch developed techniques for growing bacteria in pure culture on solid media—initially using gelatin, then agar—and for staining them. In 1882 he announced the discovery of Mycobacterium tuberculosis; in 1883, the cholera vibrio1012. His "postulates"—criteria for establishing that a particular organism causes a particular disease—became the standard of proof: the organism must be found in all cases of the disease, isolated and grown in pure culture, and reproduce the disease when inoculated into a susceptible host. Koch's postulates were not a single published list but a set of principles articulated across his work; they remain a touchstone, though they have been modified for viruses and for organisms that cannot be cultured11.

The bacteriological revolution produced a rapid succession of discoveries: Neisseria gonorrhoeae (1879), Salmonella typhi (1880), Streptococcus pneumoniae (1881), Corynebacterium diphtheriae (1883), Vibrio cholerae (1883), Clostridium tetani (1884), and many others. Each discovery promised a specific target for prevention or treatment.

Antisepsis and Asepsis

Surgery and childbirth had long been ravaged by infection. In the 1840s, Ignaz Semmelweis observed that women delivered by physicians had far higher rates of puerperal fever than those delivered by midwives, and that handwashing with chlorinated lime reduced mortality dramatically1314. His findings were rejected by much of the medical establishment, and he died in an asylum14.

The decisive change came from Joseph Lister, who in the 1860s applied Pasteur's germ theory to surgery1314. Lister used carbolic acid (phenol) to disinfect wounds, instruments, and the air, and reported striking reductions in postoperative infection. Antisepsis—killing germs after they arrive—was followed by asepsis, the strategy of keeping them out entirely through sterile instruments, gowns, gloves, and operating rooms13. By the early twentieth century, aseptic technique had become standard, and hospital-acquired infections began to be understood as a distinct problem requiring systematic control.

Serotherapy and the Antitoxin Era

The 1890s brought the first effective biological treatments1516. Emil von Behring and Shibasaburo Kitasato showed in 1890 that animals immunized against diphtheria or tetanus produced a substance in their blood—an antitoxin—that could neutralize the toxin and could be transferred to other animals or patients151617. Serum therapy for diphtheria followed, dramatically reducing mortality from a disease that had killed thousands of children each year. The principle—that antibodies from an immune animal could treat disease in another—was the first successful "magic bullet," though it was a biological rather than a chemical one.

The Chemotherapy Revolution and the Magic Bullet

Paul Ehrlich, working in the early twentieth century, pursued the idea of a chemical that would selectively target a pathogen without harming the host—the "magic bullet."1819 In 1909, with Sahachiro Hata, he identified compound 606, salvarsan (arsphenamine), as effective against syphilis. It was toxic and difficult to administer, but it was the first synthetic antimicrobial and proved the principle.

The next major step came from the sulfonamides9. In 1932, Gerhard Domagk at Bayer found that a red dye, prontosil, protected mice against streptococcal infection; the active component was sulfanilamide. Sulfonamides entered clinical use in the mid-1930s and saved lives in cases of puerperal sepsis, meningitis, and pneumonia. For the first time, a pill could cure a bacterial infection.

The Antibiotic Era

In 1928, Alexander Fleming noticed that a mold contaminating a culture plate of staphylococci had killed the bacteria around it. He named the substance penicillin but could not purify it in useful quantities. In the late 1930s and early 1940s, Howard Florey and Ernst Chain at Oxford developed methods to produce and stabilize penicillin, and by 1944 it was being mass-produced for Allied troops2021. Penicillin's effectiveness against streptococci, staphylococci, and other organisms transformed medicine21.

The antibiotic era that followed was driven largely by natural-product discovery: soil bacteria, especially Streptomyces, proved to be a rich source of new compounds. Streptomycin (1943, Selman Waksman's laboratory) was the first effective treatment for tuberculosis. Chloramphenicol, tetracycline, erythromycin, and the cephalosporins followed in the 1940s and 1950s. Each new class expanded the range of treatable infections, and each was greeted with optimism that infectious disease might soon be conquered.

Resistance and Stewardship

That optimism was premature. Fleming himself warned in his 1945 Nobel lecture that misuse of penicillin would select for resistant bacteria. Resistance emerged quickly: penicillin-resistant staphylococci were recognized in hospitals by the late 1940s, and resistance to each new drug followed within years. The mechanisms were diverse—enzymes that destroy the drug (beta-lactamases), altered drug targets, reduced permeability, and efflux pumps that expel the drug from the cell.

By the 1990s and 2000s, multidrug-resistant organisms—MRSA, vancomycin-resistant enterococci, extended-spectrum beta-lactamase-producing gram-negative bacteria, and carbapenem-resistant Enterobacteriaceae—had become major hospital problems. Antimicrobial stewardship emerged as a discipline: the systematic effort to use antibiotics only when needed, at the right dose and duration, to slow resistance and preserve drug efficacy. It combined prescribing guidelines, formulary restrictions, and rapid diagnostics.

Asymptomatic Carriage and Infection Control

A parallel strand of the field concerned patients who carried pathogens without symptoms. The recognition that individuals could harbor and transmit organisms—Salmonella typhi carriers like Mary Mallon ("Typhoid Mary"), who was identified in 1907 and quarantined for decades—made clear that infection control had to account for the invisible carrier. In hospitals, the concept of colonization—organisms present on skin or mucosa without causing disease—became central to understanding how infections spread. Hand hygiene, isolation precautions, and later screening programs for MRSA and other resistant organisms were built on this insight.

Antiviral Therapy and HIV

For most of the twentieth century, viruses resisted chemotherapy because they replicate inside host cells using host machinery. The first effective antivirals targeted herpes and influenza in the 1960s and 1970s, but progress was slow. The HIV epidemic, recognized in 1981, forced a crash program. Zidovudine (AZT), a nucleoside reverse transcriptase inhibitor, was approved in 1987, but monotherapy produced only transient benefit because the virus mutated rapidly.

The turning point was combination antiretroviral therapy (cART), introduced in the mid-1990s22. By combining drugs that targeted different steps in the viral life cycle—reverse transcriptase, protease, and later integrase—clinicians could suppress viral replication below detectable levels and prevent resistance. HIV became a manageable chronic disease rather than a fatal one2223. The same principle—combination therapy to outpace mutation—was later applied to hepatitis C, with direct-acting antivirals achieving cure rates above 90% in the 2010s.

Surveillance and Outbreak Response

The field's population-level arm developed alongside its clinical one. John Snow's cholera investigation was an early model; the founding of national public health agencies—the U.S. Public Health Service's Hygienic Laboratory in 1887 (later the National Institutes of Health), and the Centers for Disease Control in 1946—institutionalized surveillance. The World Health Organization's global influenza surveillance network, established in 1952, and its later eradication campaign against smallpox (1967–1980) demonstrated what coordinated international action could achieve. Smallpox remains the only human infectious disease to have been eradicated246.

The 2014–2016 West African Ebola epidemic and the COVID-19 pandemic exposed both the strengths and the gaps in surveillance and response, and drove investment in genomic sequencing, rapid diagnostics, and vaccine platform technologies.

The Present

Infectious diseases today is a field defined by several converging approaches. Molecular diagnostics—PCR, whole-genome sequencing, and metagenomic sequencing—allow identification of pathogens directly from clinical samples, often within hours. Antimicrobial stewardship and infection prevention remain central, now informed by genomic epidemiology that can trace transmission chains. Vaccinology has moved beyond attenuated and inactivated vaccines to mRNA platforms, deployed at scale during COVID-19. Antiviral combination therapy is standard for HIV and hepatitis C, and is expanding into other viral diseases. And the field continues to grapple with the oldest problems: tuberculosis, malaria, and sepsis remain leading causes of death globally, and the pipeline for new antibiotics is thin. The questions still open are the ones the field has always faced—how to see the invisible, how to kill it without harming the host, and how to stop it from spreading.

References

  1. Epidemiology (History), Wikipedia
  2. Humorism (Origin), Wikipedia
  3. Miasma theory, Wikipedia
  4. Vaccine (History, introduction), Wikipedia
  5. Vaccination (History), Wikipedia
  6. Smallpox vaccine, Wikipedia
  7. Edward Jenner, Wikipedia
  8. Germ theory of disease, Wikipedia
  9. Infection (Germ theory of disease), Wikipedia
  10. Koch–Pasteur rivalry, Wikipedia
  11. Koch's postulates, Wikipedia
  12. Robert Koch, Wikipedia
  13. Asepsis (History, introduction), Wikipedia
  14. Ignaz Semmelweis, Wikipedia
  15. Antiserum (History), Wikipedia
  16. Antitoxin (History of antitoxin), Wikipedia
  17. Passive immunity (History and applications of artificial passive immunity), Wikipedia
  18. Magic bullet (medicine), Wikipedia
  19. Paul Ehrlich, Wikipedia
  20. History of penicillin, Wikipedia
  21. Penicillin, Wikipedia
  22. Management of HIV/AIDS (History, introduction), Wikipedia
  23. HIV/AIDS, Wikipedia
  24. Smallpox, Wikipedia

The frameworks of Infectious Diseases

Each framework is a way of working the field has used: when it held, and the question it answers.

  1. 400 BCE-1850

    Humorism

    What balance of bodily fluids keeps a person healthy?

    Fly to its tower in Nousfarer

  2. 1500-1900

    Contagionism

    Can disease pass from one person to another?

    Fly to its tower in Nousfarer

  3. 1500-1880

    Humoral and Miasmatic Medicine

    Do disease come from the body or from the air?

    Fly to its tower in Nousfarer

  4. 1500-1880

    Miasma theory

    Does foul air from decay cause epidemics?

    Fly to its tower in Nousfarer

  5. 1796-Present

    Vaccinology

    Can a mild infection protect against a deadly one?

    Fly to its tower in Nousfarer

  6. 1850-Present

    Environmental and vector control

    Can cleaning water and killing insects stop disease?

    Fly to its tower in Nousfarer

  7. 1861-Present

    Germ theory of disease

    Do microscopic organisms cause specific diseases?

    Fly to its tower in Nousfarer

  8. 1867-Present

    Asepsis

    How can germs be kept out of wounds and surgery?

    Fly to its tower in Nousfarer

  9. 1876-Present

    Koch's postulates

    How do you prove a microbe causes a disease?

    Fly to its tower in Nousfarer

  10. 1887-Present

    Surveillance and outbreak response

    How do we detect and track outbreaks as they happen?

    Fly to its tower in Nousfarer

  11. 1890-1945

    Antiserum

    Can antibodies from an immune animal cure disease?

    Fly to its tower in Nousfarer

  12. 1900-Present

    Infection prevention and control

    How do hospitals stop infections from spreading inside them?

    Fly to its tower in Nousfarer

  13. 1909-Present

    Magic bullet

    Can a chemical kill a germ without harming the patient?

    Fly to its tower in Nousfarer

  14. 1940-1990

    Natural-product antibiotic discovery

    Can molds and microbes yield drugs that cure infections?

    Fly to its tower in Nousfarer

  15. 1990-Present

    Antimicrobial resistance and stewardship

    How do we keep antibiotics working as resistance grows?

    Fly to its tower in Nousfarer

  16. 1990-Present
  17. 1996-Present

    Combination antiviral therapy

    Can several drugs together control a persistent virus?

    Fly to its tower in Nousfarer

How the ideas connect

Each arrow runs from an earlier idea to the later one it shaped. The list below says what passed between them.

HumorismContagionismHumoral and Miasmatic MedicineMiasma theoryVaccinologyEnvironmental and vector controlGerm theory of diseaseAsepsisKoch's postulatesSurveillance and outbreak responseAntiserumInfection prevention and controlMagic bulletNatural-product antibiotic discoveryAntimicrobial resistance and stewards…Molecular diagnostics and genomic epi…Combination antiviral therapy

Beyond the field

Where Infectious Diseases's ideas came from in other fields, and what they led to there: the strongest 12 of 119 links.

A city in Nousfarer: a red-carpeted stair climbing terraces to a crowned tower on an acropolis, more towers round it, forest and snowy mountains beyond.
A city in Nousfarer, the game played in the browser.

Infectious Diseases is a planet in Nousfarer

Its city has a tower for each of these 17 frameworks. Land, walk in, and climb one concept at a time.

Land on Infectious Diseases

Related fields

Fields its ideas are linked to

More in Internal Medicine

See where Infectious Diseases sits on the Map of Human Knowledge